Categorized | Legal News

Medtronic Faces Repercussions because of the Court’s Reversal

Medtronic may not be a big fan of the Appellate Court these days, and with good reason. The company is back to facing a negligence lawsuit because of an off-label use of their product Infuse. The situation goes like this; a male patient underwent spinal surgery. The surgeon used Infuse. The patient went numb. A lawsuit arose. A demur was filed. The trial court sustained the demur. The Appellate court reversed it.

 

The heart of the matter, however, is based in the off-label use. The Food and Drug Administration (FDA) had approved Infuse for certain kinds of surgery – specifically, ones where the incision during the surgery was made in the abdomen. In the case discussed here, the surgeon made the incision elsewhere, and the patient suffered post-surgery with pain and numbness. When the patient-turned plaintiff filed suit, Medtronic demurred stating that the grounds under which he filed (a California state law which requires that patients be warned about potential adverse side-effects) was preempted by the federal Medical Device Act, which allows doctors to use devices in an off-label manner but prohibits manufacturers from advertising them for such uses.

 

This case could have far-reaching repercussions in how manufacturers promote their products, especially to the FDA. We could see far more negligence and liability cases in the future, if they don’t.

Comments are closed.

Product Safety News

Archives